Compounds represented by Formula (I) or pharmaceutically acceptable salts thereof, are effective as NMDA NR2B antagonists useful for treating conditions such as, for example, Parkinson's disease, Alzheimer's disease, migraine, epilepsy and pain.
申请公布号
KR20060017839(A)
申请公布日期
2006.02.27
申请号
KR20057023218
申请日期
2005.12.02
申请人
MERCK & CO., INC.
发明人
LIVERTON NIGEL J.;CLAIBORNE CHRISTOPHER F.;CLAREMON DAVID A.;MCCAULEY JOHN A.
